1. Home
  2. MAX vs ARCT Comparison

MAX vs ARCT Comparison

Compare MAX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAX
  • ARCT
  • Stock Information
  • Founded
  • MAX 2014
  • ARCT 2013
  • Country
  • MAX United States
  • ARCT United States
  • Employees
  • MAX N/A
  • ARCT N/A
  • Industry
  • MAX Industrial Machinery/Components
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAX Industrials
  • ARCT Health Care
  • Exchange
  • MAX Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • MAX 582.4M
  • ARCT 298.3M
  • IPO Year
  • MAX 2020
  • ARCT N/A
  • Fundamental
  • Price
  • MAX $10.35
  • ARCT $13.78
  • Analyst Decision
  • MAX Strong Buy
  • ARCT Strong Buy
  • Analyst Count
  • MAX 6
  • ARCT 8
  • Target Price
  • MAX $17.92
  • ARCT $52.83
  • AVG Volume (30 Days)
  • MAX 405.8K
  • ARCT 474.9K
  • Earning Date
  • MAX 07-30-2025
  • ARCT 08-04-2025
  • Dividend Yield
  • MAX N/A
  • ARCT N/A
  • EPS Growth
  • MAX N/A
  • ARCT N/A
  • EPS
  • MAX 0.28
  • ARCT N/A
  • Revenue
  • MAX $1,002,364,000.00
  • ARCT $143,680,000.00
  • Revenue This Year
  • MAX $24.09
  • ARCT N/A
  • Revenue Next Year
  • MAX $11.18
  • ARCT $34.79
  • P/E Ratio
  • MAX $37.20
  • ARCT N/A
  • Revenue Growth
  • MAX 148.62
  • ARCT 15.38
  • 52 Week Low
  • MAX $7.33
  • ARCT $8.04
  • 52 Week High
  • MAX $20.91
  • ARCT $25.88
  • Technical
  • Relative Strength Index (RSI)
  • MAX 45.90
  • ARCT 54.34
  • Support Level
  • MAX $10.05
  • ARCT $13.10
  • Resistance Level
  • MAX $11.14
  • ARCT $15.20
  • Average True Range (ATR)
  • MAX 0.37
  • ARCT 1.02
  • MACD
  • MAX -0.07
  • ARCT 0.07
  • Stochastic Oscillator
  • MAX 26.43
  • ARCT 55.21

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: